Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shot
1. 系统已在2025-12-22 17:27:57对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1097/MOG.0000000000001083
文献链接: https://journals.lww.com/10.1097/MOG.0000000000001083
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Eda Kaya; Wing-Kin Syn; Paul Manka

